Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development

被引:151
作者
Reddy, P
Shena, LJ
Ren, C
Boman, K
Lundin, E
Ottander, U
Lindgren, P
Liu, YX
Sun, QY
Liu, K [1 ]
机构
[1] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden
[2] Umea Univ, Dept Radiat Sci, S-90187 Umea, Sweden
[3] Umea Univ, Dept Med Biosci Pathol, S-90187 Umea, Sweden
[4] Umea Univ, Dept Clin Sci Obstet & Gynecol, S-90187 Umea, Sweden
[5] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100080, Peoples R China
关键词
mammalian oocytes; stem cell factor (SCF); Kit; PI3; kinase; Akt; FKHRL1;
D O I
10.1016/j.ydbio.2005.02.013
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although communications between mammalian oocytes and their surrounding granulosa cells mediated by the Kit-Kit ligand (KL, or stem cell factor, SCF) system have been proven to be crucial for follicular development, Kit downstream signaling pathways in mammalian oocytes are largely unknown. In this study, by using ovaries and isolated oocytes from postnatal mice and rats, we demonstrated for the first time that components of the PI3 kinase pathway, the serine/threonine kinase Akt (PKB) which enhances cellular proliferation and survival, and an Akt substrate FKHRL1 which is a transcription factor that leads to apoptosis and cell cycle arrest, are expressed in mammalian oocytes. By using an in vitro oocytes culture system, we found that oocytes-derived Akt and FKHRL1 are regulated by SCF. Treatment of cultured oocytes with SCF cannot only rapidly phosphorylate and activate Akt, but also simultaneously phosphorylate and may therefore functionally suppress FKHRL1, through the action of PI3 kinase. Together with our in situ hybridization and immunohistochemistry data that Akt and FKHRL1 are mostly expressed in oocytes in primordial and primary ovaries and reports that FKHRL1 gene-deficient mice exhibited excessive activation from primordial to primary follicles as well as enlarged oocyte sizes, we suppose that in mammalian oocytes, actions of granulosa cell derived SCF on primordial to primary follicle transition and subsequent follicle development may involve activation of Akt and inhibition of FKHRL1 activities in oocytes. The role of oocyte's Akt may be to enhance follicle development and the role of oocyte's FKHRL1 may be to inhibit follicle development. We propose that the cascade from granulosa cell SCF to oocyte Kit-PI3 kinase-Akt-FKHR1 1 may play an important role to regulate the growth rate of mammalian oocytes and hypothetically also the oocyte secretion of factors that may regulate the activation and early development of ovarian follicles. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:160 / 170
页数:11
相关论文
共 46 条
[1]   FoxOs at the crossroads of cellular metabolism, differentiation, and transformation [J].
Accili, D ;
Arden, KC .
CELL, 2004, 117 (04) :421-426
[2]  
Albertini DF, 2003, REPRODUCTION, P49
[3]  
BESMER P, 1993, DEVELOPMENT, P125
[4]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[5]   FoxO3a eggs on fertility and aging [J].
Brenkman, AB ;
Burgering, BMT .
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (11) :464-467
[6]   Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a [J].
Castrillon, DH ;
Miao, LL ;
Kollipara, R ;
Horner, JW ;
DePinho, RA .
SCIENCE, 2003, 301 (5630) :215-218
[7]   Growth differentiation factor-9 is required during early ovarian folliculogenesis [J].
Dong, JW ;
Albertini, DF ;
Nishimori, K ;
Kumar, TR ;
Lu, NF ;
Matzuk, MM .
NATURE, 1996, 383 (6600) :531-535
[8]   Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary [J].
Elvin, JA ;
Yan, CN ;
Wang, P ;
Nishimori, K ;
Matzuk, MM .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (06) :1018-1034
[9]  
Elvin JA, 1998, REV REPROD, V3, P183, DOI 10.1530/revreprod/3.3.183
[10]   Oocyte control of ovarian follicular development and function in mammals [J].
Eppig, JJ .
REPRODUCTION, 2001, 122 (06) :829-838